Drugs / Cord Blood Serum (CBS) Eye Drops
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06830551 | Sep 2023 → Dec 2025 overdue | dry eye syndrome | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cord Blood Serum (CBS) Eye Drops | “Personalized Approach in the Treatment of Patients Affected by Severe Dry Eye Associated With Therapy With EGFR Inhibitors (EGRFR-I) With Growth Factors in Cord Blood Serum...” NCT06830551 ↗ |
| Known as | Cord Blood Serum Eyes Drops | “The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment” NCT06830551 ↗ |
| Modality | Protein / enzyme biologic | “With Growth Factors in Cord Blood Serum (CBS) Eye Drops” NCT06830551 ↗ |
| Route | Topical | “administration cord blood based eye drops customized to deliver epitelio tropic factors, incluiding EGF in EGFR blocked cells” NCT06830551 ↗ |